TNF--Elicited miR-29b Potentiates Resistance to Apoptosis in Peripheral Blood Monocytes From Patients With Rheumatoid Arthritis
Yes, there is no medical contraindication to starting GLP-1 therapy on any particular day
In November 2025, after a pause of more than five years, the FDA approved a reformulated version of H2 blocker ranitidine that addresses the shelf-life deficiencies and impurities present in the previous versions
GHK-Cu can be used in addition for scalp support
When to seek medical advice: Persistent, excessive hunger despite adequate food intake Unintentional weight loss exceeding 5% of body weight over 612 months Hunger accompanied by excessive thirst, frequent urination, or fatigue (potential diabetes symptoms) Severe abdominal pain, persistent vomiting, black or bloody stools, or marked abdominal distension Significant changes in bowel habits alongside altered hunger patterns Concerns about disordered eating behaviours or preoccupation with food Your GP can arrange appropriate investigations, including blood tests for thyroid function, glucose metabolism, and nutritional deficiencies, and provide referral to dietetic services or specialist eating disorder services (see NICE NG69: Eating disorders: recognition and treatment) where indicated
Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors
